Verastem Oncology Revenue

Biotechnology Research • Needham, Massachusetts, United States • 101-200 Employees

Verastem Oncology revenue & valuation

Annual revenue	$2,137,000
Revenue per employee	$17,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,900,000
Total funding	$122,500,000

Key Contacts at Verastem Oncology

Vikram Jagannathan

Associate Medical Director- Clinical Development

Cindy Jou Meyers

Senior Director, Regulatory Advertising And Promotion

Christiane Carney

National Field Leader, Senior Director Medical Affairs Solid Tumor

Yatin Patel Technology

Director, Product Development, Manufacturing And Cmc

Eddie Dowling

Oncology Regional Sales Director - East

Genevieve Klim

Director, Digital

Tayyeb Din

Associate Director, Clinical Safety And Risk Management

Patrick Kec

Regional Sales Director

Michael Polkowitz

Strategic Account Director - Gpo/Organized Customers

John Redue

Director, Medical Writing

Company overview

Headquarters	117 Kendrick Street, Suite 500, Needham, Massachusetts 02494, US
Phone number	+17812924200
Website	verastem.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Pharmaceutical, Oncology, Clinical Trials, Cancer Research, Cancer
Founded	2010
Employees	101-200
Socials

Verastem Oncology Email Formats

Verastem Oncology uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@verastem.com), used 61.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@verastem.com	61.5%
{last name}{last name}	doedoe@verastem.com	38.5%

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com. X/Twitter: @VerastemOncolog

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Manager

Senior

Employees by Department

Verastem Oncology has 67 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Verastem Oncology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-02-24	14	$60,000,000
2024-08-23	14	$55,000,000
2025-02-13	14	$7,500,000

Funding Insights

$122,500,000

Total funding amount

$7,500,000

Most recent funding amount

Number of funding rounds

Verastem Oncology Tech Stack

Discover the technologies and tools that power Verastem Oncology's digital infrastructure, from frameworks to analytics platforms.

AddThis

Widgets

Vimeo

Video players

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Redux Framework

WordPress plugins

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

MailChimp

Google Analytics

Analytics

Bootstrap

UI frameworks

Frequently asked questions

Verastem Oncology is located in Needham, Massachusetts, US.

You can reach Verastem Oncology at +17812924200.

Verastem Oncology generates an estimated annual revenue of $2,137,000. This revenue figure reflects the company's market position and business performance in its industry.

Verastem Oncology has an estimated valuation of $6,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Verastem Oncology was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Verastem Oncology has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Verastem Oncology has raised a total of $122,500,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.